# Bombay Super Hybrid Seeds share price today (Bombay Super Hybrid Seeds Ltd, NSE: BSHSL)

> Bombay Super Hybrid Seeds share price today: ₹85.27 at the NSE close on 3 November 2026, down 30.2% in a year. Bombay Super Hybrid Seeds (NSE: BSHSL) is worth ₹895 crore, trades at a P/E of 31.1 and has closed between ₹67.37 and ₹119.32 over the past 52 weeks. > Bombay Super Hybrid Seeds Ltd's earnings have grown faster than its share price. Earnings per share grew +0.8% in a year while the price moved −30.2%. BSHSL · Seeds/Tissue Culture/Bio Technology · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/bombay-super-hybrid-seeds-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹85.27 (−30.2% in a year)
- P/E: 31.1× (lower than 92% of the last 8.5 years)
- Revenue (Sep 2026): ₹85.9 Cr (+219.8% on a year ago)
- Profit (Sep 2026): ₹2.4 Cr (+5.4% on a year ago)
- Operating margin: 5.0% (−10.5 points on a year ago)
- ROCE: 16%, FY26
- ROIC: 16.8%, against a 12.0% cost of capital: +4.8 points

The main question: profits are rising, but only −47% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Bombay Super Hybrid Seeds share price today? Bombay Super Hybrid Seeds Ltd's share price was ₹85.27 at the close on 3 November 2026. It has been falling for 140 weeks. That is 10.0% below its average price over the last 200 trading days. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 5 weeks in a row. In the last 52 weeks it traded between ₹67 and ₹119, and at that close it sat 34% of the way up from that low. Over the last 8.5 years the share price moved +1,955% while the NIFTY 500 moved +132%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Bombay Super Hybrid Seeds this quarter? One change stood out: lowest operating margin in 16 quarters. 1. Lowest operating margin in 16 quarters Operating margin was 5% in the September 2026 quarter, against 15.5% a year earlier. ## What are Bombay Super Hybrid Seeds' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Bombay Super Hybrid Seeds reported revenue of ₹85.9 crore, up 219.8% from ₹26.9 crore a year earlier, and a profit of ₹2.36 crore, up 5.4% from ₹2.24 crore. ### Bombay Super Hybrid Seeds results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹85.9 crore | ₹26.9 crore | +219.8% |
| Profit | ₹2.36 crore | ₹2.24 crore | +5.4% |
| Earnings per share | ₹0.22 | ₹0.21 | +4.8% |
| Operating margin | 5.0% | 15.5% | −10.5 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Bombay Super Hybrid Seeds share price history? Bombay Super Hybrid Seeds closed at ₹85.27 on 3 November 2026, down 30.2% from ₹122.25 a year earlier (31 October 2025) and up 203.9% over five years. Its highest weekly close since April 2018 was ₹634.00 on 3 February 2023. ### Bombay Super Hybrid Seeds share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹83.53 | +2.1% |
| 1 month ago · 1 Oct 2026 | ₹83.95 | +1.6% |
| 6 months ago · 30 Apr 2026 | ₹98.45 | −13.4% |
| 1 year ago · 31 Oct 2025 | ₹122.25 | −30.2% |
| 3 years ago · 3 Nov 2023 | ₹216.90 | −60.7% |
| 5 years ago · 4 Nov 2021 | ₹28.06 | +203.9% |
| Earliest and lowest weekly close in our records · 27 Apr 2018 | ₹4.15 | +1,954.7% |
| Highest weekly close since April 2018 · 3 Feb 2023 | ₹634.00 | −86.6% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹119.32 | −28.5% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹67.37 | +26.6% |

Weekly closing prices, adjusted for splits and bonuses so every price is on today’s share count. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (451 weekly closes from 27 April 2018 to 3 November 2026.)

## What is the latest news on Bombay Super Hybrid Seeds? 3 Nov 2026: Bombay Super Hybrid Seeds closed at ₹85.27, up 2.1% on the week and up 1.6% on the month. Results for July to September 2026: Revenue up 219.8% and profit up 5.4% on a year earlier. ## What dividend does Bombay Super Hybrid Seeds pay? Bombay Super Hybrid Seeds has paid no dividend on the NSE since 1 April 2021, the start of the period we checked. No. Bombay Super Hybrid Seeds Ltd paid out 0% of its profit as dividends in each of its last 12 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## Which stock lists is Bombay Super Hybrid Seeds on? Bombay Super Hybrid Seeds is on one of our India lists: Penny stocks. [Penny stocks Earnings growth, 12 months (%): 3.79](https://www.sectoralpha.in/penny-stocks-india)

## Is Bombay Super Hybrid Seeds profitable? Bombay Super Hybrid Seeds Ltd earned ₹2.4 Cr of net profit in the Sep 2026 quarter, +5.4% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹27.0 Cr. That is 2.7% of the quarter's revenue. The same quarter a year earlier earned ₹2.2 Cr. For the full year, FY26 profit was ₹27.0 Cr (+3.8% on the year before). Why profit moved: revenue changed +219.8% on a year earlier and the margin moved −10.5 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed +3.1% and revenue +65.1%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Bombay Super Hybrid Seeds make, and is it growing? Bombay Super Hybrid Seeds Ltd reported ₹85.9 Cr of revenue in the Sep 2026 quarter, +219.8% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 18.5% a year on average. The last full year, FY26, came in at ₹344 Cr. The last four reported quarters add to ₹433 Cr. FY26 revenue was ₹344 Cr, −3.9% on the year before. Recent pace: the last four quarters grew +65.1% on average, against 18.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +22.4%, against +21.9% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +3.9%, against +11.4% a year (rolling over). ## How much of every ₹100 of sales does Bombay Super Hybrid Seeds keep? Bombay Super Hybrid Seeds Ltd's operating margin was 5.0% in the Sep 2026 quarter, 10.5 percentage points lower than the same quarter a year ago. Across 12 years it has been between 1.3% and 11.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −10.5 percentage points on the year while gross margin changed −18.7 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Bombay Super Hybrid Seeds' profit turning into cash? Over the last 3 years Bombay Super Hybrid Seeds Ltd's operations used more cash than they brought in, so cash conversion was −47%, a gap worth watching. In FY26 its operations used ₹16.0 Cr of cash, against ₹27.0 Cr of profit. After ₹3.0 Cr of spending on assets, free cash was −₹19.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why −47% of profit came in as cash: the cash cycle got 265 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 265 days longer. The next section looks at where the cash is stuck. ## Where does Bombay Super Hybrid Seeds' cash go? Bombay Super Hybrid Seeds Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 444 days in FY26, up from 179 days in FY21. It spent ₹5.0 Cr on assets over the last 3 years. Customers take 10 days to pay, and stock sits for 439 days on average. At FY26 sales of ₹344 Cr, each day of that cycle ties up about ₹0.9 Cr, so roughly ₹418 Cr is tied up in the business at any time. FY26: customers took 10 days to pay and stock sat for 439 days, about 14.4 months of sales sitting as stock, for a full cycle of 444 days, longer than FY21's 179. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 439 days. Customers pay about 10 days after that. Suppliers are paid at 5 days. Together that makes the 444-day cycle. Spending on assets: ₹5.0 Cr over the last 3 years, against ₹4.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Bombay Super Hybrid Seeds' P/E ratio, and how does it compare with its own history? Bombay Super Hybrid Seeds Ltd's P/E is 31.1×, near the low end of its own history: it has been lower only 8% of the time. Its usual P/E (the middle reading) is 52.9×, over 8.5 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +0.8% while the price moved −30.2%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +24.9% a year; about +23.9% a year came from earnings growth and about +1.0 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Bombay Super Hybrid Seeds business getting better or worse? Bombay Super Hybrid Seeds Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE falling at 25.0%; each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Bombay Super Hybrid Seeds earn on its capital? Bombay Super Hybrid Seeds Ltd earned a ROCE of 16% in FY26. That is up from a low of 10% in FY16. Its return on capital used (ROIC) is 4.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 7.8% net margin and 1.35× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 7.8% net margin × 1.35× asset turnover × 1.94× leverage (assets divided by equity) ≈ 20.4% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 16.8% − 12.0% = +4.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 16.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 14.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Bombay Super Hybrid Seeds have too much debt? Bombay Super Hybrid Seeds Ltd has total debt of ₹23.0 Cr against shareholder equity of ₹148 Cr as of Sep 2026, so its debt is 0.16× its equity, which is very little. Year by year, that ratio went from 1.00 in FY22 to 0.82 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Bombay Super Hybrid Seeds shareholding pattern? No group of Bombay Super Hybrid Seeds Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved +0.0 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: +0.0 points over 8 quarters, to 73.8%; Foreign institutions: +0.0 points over 8 quarters, to 0.0%. ## How far is Bombay Super Hybrid Seeds from balance-sheet trouble? For Bombay Super Hybrid Seeds Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Bombay Super Hybrid Seeds rank in its industry? 49.0 out of 100, rank 2 of 3 in Seeds/Tissue Culture/Bio Technology, with 97% of the evidence available. Bombay Super Hybrid Seeds Ltd scores 49.0 out of 100 against the 3 companies it is compared with in Seeds/Tissue Culture/Bio Technology, ranking 2. Relative strength against the index is -6.5%, and revenue and profit growth are weak. The four parts add up to the total exactly: 11.2 + 12.8 + 11.1 + 13.9 = 49. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Bombay Super Hybrid Seeds compared with? Bombay Super Hybrid Seeds ranks 2 of 3 Seeds/Tissue Culture/Bio Technology companies on the 4-Factor Sector Score, with 49.0 out of 100. 1. [Advanced Enzyme Technologies Ltd](https://www.sectoralpha.in/stocks/advanced-enzyme-technologies-ltd) ADVENZYMES · quiet · Evidence leans up · 79% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.2/35 · Revenue 10.6% · Profit 17.9% · Operating margin change 1 points · 95% evidence Capital efficiency 15.5/25 · ROCE 14% · Operating margin 34% · 76% evidence Valuation 12.5/20 · P/E 18.2× · PEG n/a · 35% evidence Relative strength 4.4/20 · Lead over its industry -0.1% · Lead over NIFTY 500 -10.1% · 1 year -14.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 21.2 + 15.5 + 12.5 + 4.4 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. Bombay Super Hybrid Seeds Ltd this page BSHSL · turning · Evidence leans down · 97% evidence 49.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue 22.4% · Profit 3.9% · Operating margin change -10.5 points · 100% evidence Capital efficiency 12.8/25 · ROCE 16% · Operating margin 5% · 100% evidence Valuation 11.1/20 · P/E 30.3× · PEG 2.15 · 85% evidence Relative strength 13.9/20 · Lead over its industry 3.8% · Lead over NIFTY 500 -6.5% · 1 year -32% · 100% evidence · 2 of 12 weeks ahead Exact sum: 11.2 + 12.8 + 11.1 + 13.9 = 49 · What this means: Relative strength against the index is -6.5%, and revenue and profit growth are weak. 3. [Rossari Biotech Ltd](https://www.sectoralpha.in/stocks/rossari-biotech-ltd) ROSSARI · quiet · Evidence leans down · 97% evidence 47.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.4/35 · Revenue 19.8% · Profit 11.7% · Operating margin change 0 points · 100% evidence Capital efficiency 13.4/25 · ROCE 13.3% · Operating margin 12% · 100% evidence Valuation 14.9/20 · P/E 14.5× · PEG 1.42 · 85% evidence Relative strength 0.0/20 · Lead over its industry -8.3% · Lead over NIFTY 500 -17.4% · 1 year -37.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.4 + 13.4 + 14.9 + 0 = 47.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Seeds/Tissue Culture/Bio Technology](https://www.sectoralpha.in/sectors/seeds-tissue-culture-bio-technology), all 3 compared on one page. ## Which companies are close to Bombay Super Hybrid Seeds in size? Bombay Super Hybrid Seeds is the 3rd largest of 3 Seeds/Tissue Culture/Bio Technology companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Advanced Enzyme Technologies and Rossari Biotech. It is the smallest. ### Seeds/Tissue Culture/Bio Technology companies close in size

1. [Advanced Enzyme Technologies Ltd](https://www.sectoralpha.in/stocks/advanced-enzyme-technologies-ltd) ₹2,951 crore
2. [Rossari Biotech Ltd](https://www.sectoralpha.in/stocks/rossari-biotech-ltd) ₹2,212 crore
3. Bombay Super Hybrid Seeds Ltd ₹873 crore

[All 3 Seeds/Tissue Culture/Bio Technology companies, largest first](https://www.sectoralpha.in/sectors/seeds-tissue-culture-bio-technology#all-companies)

### Companies close in size in other industries

1. [Bizotic Commercial Ltd](https://www.sectoralpha.in/stocks/bizotic-commercial-ltd) ₹874 crore · Trading
2. [Sastasundar Ventures Ltd](https://www.sectoralpha.in/stocks/sastasundar-ventures-ltd) ₹874 crore · Pharmacy Distribution
3. Bombay Super Hybrid Seeds Ltd ₹873 crore
4. [Themis Medicare Ltd](https://www.sectoralpha.in/stocks/themis-medicare-ltd) ₹873 crore · Pharma - API
5. [Wealth First Portfolio Managers Ltd](https://www.sectoralpha.in/stocks/wealth-first-portfolio-managers-ltd) ₹868 crore · Finance - Capital Markets

## What else do people ask about Bombay Super Hybrid Seeds? ### What is Bombay Super Hybrid Seeds's share price today? Bombay Super Hybrid Seeds Ltd's share price is ₹85.27, −30.2% over the past year. The whole company is worth ₹895 Cr on the market. In the last 52 weeks it traded between ₹67 to ₹119; today it is 34% of the way up from the low, 10.0% below its 200-day average (as of 3 November 2026). ### What were Bombay Super Hybrid Seeds's latest quarterly results? Bombay Super Hybrid Seeds Ltd reported revenue of ₹85.9 Cr and net profit of ₹2.4 Cr for the Sep 2026 quarter. Revenue rose 219.8% and profit rose 5.4% compared with a year earlier. Earnings per share were ₹0.22 (as of 3 November 2026). ### What is Bombay Super Hybrid Seeds's market cap? Bombay Super Hybrid Seeds Ltd's market capitalisation is ₹895 Cr at a share price of ₹85.27. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### What is Bombay Super Hybrid Seeds's P/E ratio? Bombay Super Hybrid Seeds Ltd's P/E is 31.1×, higher than 8% of its own last 9 years. Its usual level (the middle reading) is 52.9×. This compares the price with the company's own past; it is not a view on what the shares are worth (as of 3 November 2026). ### How is Bombay Super Hybrid Seeds valued against its own history? Against its own history, Bombay Super Hybrid Seeds Ltd's valuation is low: its P/E of 31.1× has been lower only 8% of the time in 9 years (usual level 52.9×). This compares the price with the company's own past; it is not a view on what the shares are worth or where the price goes next (as of 3 November 2026). ### How is Bombay Super Hybrid Seeds performing? Bombay Super Hybrid Seeds Ltd's share price has been falling for 140 weeks. In its latest quarter, revenue rose 219.8% and profit rose 5.4% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 5 weeks running (as of 3 November 2026). ### Will Bombay Super Hybrid Seeds's share price go up? This page does not forecast Bombay Super Hybrid Seeds Ltd's share price. What it shows instead: the share price is ₹85.27, and it has been falling for 140 weeks. Its P/E of 31.1× is higher than 8% of its own last 9 years (as of 3 November 2026). ### Who owns Bombay Super Hybrid Seeds? Promoters own 73.8% of Bombay Super Hybrid Seeds Ltd, foreign institutions 0.0%, domestic institutions, and the public 26.1% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Does Bombay Super Hybrid Seeds have too much debt? Bombay Super Hybrid Seeds Ltd has a moderate amount of debt: its debt is 0.82× its equity, and its operating profit is 5 times its interest bill. FY26 borrowings were ₹108 Cr against equity of ₹131 Cr. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Bombay Super Hybrid Seeds in its business cycle? Bombay Super Hybrid Seeds Ltd's FY26 operating margin was 10.0%, against a 12-year range of 1.3% to 11.0%: the middle of its own range, neither a peak nor a low. The latest quarter was 5.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Bombay Super Hybrid Seeds story? The main question: profits are rising, but only −47% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Bombay Super Hybrid Seeds a stock worth studying right now? What the numbers show: Bombay Super Hybrid Seeds Ltd's earnings have grown faster than its share price. Earnings per share grew +0.8% in a year while the price moved −30.2%. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ## Lists

- Penny stocks: https://www.sectoralpha.in/penny-stocks-india

This is research, not advice. We’re not SEBI-registered.